Receive funding for your R&D Projects!
Your partner for subsidy advice
Your partner for subsidy advice
Vaccine based on adenoviral vectors to prevent infection with the respiratory syncytial virusFurther Information: PDF rubitec – Gesellschaft für Innovation und…
Professor Ritter and his co-workers from the Division of Virology, University Hospital of the RWTH Aachen, created a new recombinant Epstein-Barr Virus (EBV)
which has lost the ability to enter the state of latent persistency after infecting host cells. The mutant virus only causes a self-limited infection and is unable to immortalize B-lymphocytes following Infection. Having lost the oncogenic potential of wild type EBV it fulfils the prerequisite for a live vaccine.
The inventors generated a mutant virus allowing expression of lytic genes, but preventing the expression of EBV encoded genes essential for the establishment of
viral latency. Mutant virus infected B-lymphocytes died after the productive phase….
ONF-MicroMod provides an upgrade for commercially
available laboratory microscopes. Several modules expand a given microscope by a novelty filter based on…
With the newly developed tool spindle system conventional spindle rotors and the tool holding fixtures connected with it can be set aside by means of direct…
The invention covers a new kind of monolithically integrated optical fiber coupling and their fabrication method.Further Information: PDF Technologie-Lizenz-Büro (TLB) der Baden-Württembergischen Hochschulen GmbH…
At the University of Stuttgart (Germany) a new method and device were developed, which demodulates optical signals with 3 bit information per signal with at…